噻托溴铵联合布地奈德福莫特罗吸入治疗慢阻肺的临床效果观察

  • 打印
  • 收藏
收藏成功


打开文本图片集

【摘要】目的:讨论慢阻肺患者在采取噻托溴铵联合布地奈德福莫特罗吸入治疗时的效果。方法:2020年1月—2021年11月,共计纳入我院慢阻肺患者40例,以掷硬币法均分为试验组和对照组;对照组选择噻托溴铵治疗,试验组在对照组基础上联合布地奈德福莫特罗吸入治疗,比较两组疗效。结果:两组治疗前肺功能指标无统计学差异(P>0.05);治疗后,两组肺功能指标比较差异有统计学意义(P0.05);治疗后,两组血气指标比较差异有统计学意义(P0.05);治疗后,两组炎症因子比较差异有统计学意义(P

【关键词】慢阻肺;噻托溴铵;布地奈德福莫特罗;肺功能

Clinical effect of tiotropium bromide combined with budesonide and formoterol inhalation in the treatment of chronic obstructive pulmonary disease

TANG Yan, GUO Li, ZHAO Jun

Neijiang Health Vocational College, Neijiang, Sichuan 641100, China

【Abstract】Objective: To investigate the effect of tiotropium bromide combined with budesonide and formoterol inhalation in patients with COPD.Methods: From January 2020 to November 2021,a total of 40 patients with COPD were admitted to our hospital and divided into the experimental group and the control group by coin operation method;The control group was treated with tiotropium bromide,and the experimental group was treated with budesonide and formoterol inhalation on the basis of the control group.The efficacy of the two groups was compared.Results:There was no significant difference in lung function indexes between the two groups before treatment(P>0.05);After treatment,there was statistically significant difference in lung function indexes between the two groups(P0.05);After treatment,there was statistically significant difference in blood gas indexes between the two groups(P0.05);After treatment,there was statistically significant difference in inflammatory factors between the two groups(P

【Key Words】COPD; Tiotropium bromide; Budesonide formoterol; Lung function

慢阻肺在临床中作为十分常见的一项呼吸内科疾病,该病的发生主要是由于气流受限,且病情呈进行性发展。(剩余4310字)

目录
monitor